The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
....both for steady increase in SP and dividends. Recent high is £9.50 and our dividend is well covered, so good reason to be confident.
Remember this co is a spin off by KLK which is one of the oldest and best established cos in Asia. I have full confidence that with that lineage, they have made the right decision and will get the best deal.
...remember China is not the cash cow it used to be. See KZG, which I also hold. For those not yet invested here, this is a great opportunity.
When I spoke to the co some while ago they were pretty confident. Remember was rather surprised to actually get through!
...NOT soon....this will probably be fought over as a bid stock when Lupuzor gets nearer approval. Probably not for
wrinklies like me but not selling!
...you should not be out of these over coming weekend! I expect a 150% spike when it appears.
Reckon they've received a bit of a wink, so topped up again. Think the ink may be drying on the JV!
All WRONG. US facing a chaos general election. US economy even more over-borrowed than UK. My advice is hang on here!
This could now be 'Happy New Year'for GSK holders. P.E of 9.6 ,way below other pharma average of over 20 and decent part year figures expected soon. Glad to be heavily in these right now.
.....likely in a week or so. Tightly held share so good news could move the SP sharply.
Daytradenovice - your chosen name says to me 'this is not for you! I just reread their last RNS and still feel this is worth waiting for,even if some of the plans take longer to become reality. Just wish I could attend the London meeting but busy that day.
My hunch as well!
...and as a Type2 diabetic of 76 with Class 4 Kidney Disease, quite interested. Sure it is spending masses of money, but it is an expensive field they are in and will no doubt be sending round the begging bowl more than once before they have an approved product. My p/f is full right now but will try to remember to keep an eye on RENX.
...I would not be surprised at all if the SP moved - in a decent market- over £5 per share. Dependant upon how the cash pile is to be invested, it is not impossible for the NAV in due course to return to, or even exceed its previous giddy heights. But I would be more comfortable if the excess cash was spent fairly slowly and with great care. Ms Blanc is proving herself to be one smart lady, so I expect nothing less.
Get the market to believe that our unloved Dame is moving on!!
...seems to have been their month for producing yearly figures so I am willing to give them until then to give us meaningful news, rather than hope to cling on to!
Like you I hope for good things here in 2024. The two principals here have a huge interest and I have myself been a holder for over a decade but would not be surprised if the progress did not live up to my best hopes. That's the Africa effect I'm afraid. Maybe BP could do us a favour!
...only slow rise until Feb then little sharper rise until next RNS and increased divi in March. Very desirable London properties.
Seems like I probably am alone in my sentiment here. International infrastructure is also tipped for being more essential
than ever so with continuing emphasis on reducing emissions worldwide, I see this as moving higher still in the next 6 months or so.
Don't know but sounds fishy to me! Maybe the CRO planning to get his work done on the cheap?